(NASDAQ: LSTA) Lisata Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.31%.
Lisata Therapeutics's earnings in 2025 is -$19,308,000.On average, 2 Wall Street analysts forecast LSTA's earnings for 2025 to be -$23,000,196, with the lowest LSTA earnings forecast at -$23,988,989, and the highest LSTA earnings forecast at -$22,011,402. On average, 1 Wall Street analyst forecast LSTA's earnings for 2026 to be -$10,747,755, with the lowest LSTA earnings forecast at -$10,747,755, and the highest LSTA earnings forecast at -$10,747,755.
In 2027, LSTA is forecast to generate -$11,435,611 in earnings, with the lowest earnings forecast at -$11,435,611 and the highest earnings forecast at -$11,435,611.